AstraZeneca PLC
(OSTO:AZN)
kr
1641
-6 (-0.36%)
Market Cap: 2.54 Til
Enterprise Value: 2.82 Til
PE Ratio: 38.20
PB Ratio: 6.49
GF Score: 88/100 - Q1 2024 AstraZeneca PLC Earnings Call TranscriptApr 25, 2024kr1641.5 (+6.35%)Earnings
- AstraZeneca PLC Sustainability 2023 Highlights Summary Call TranscriptMar 22, 2024
- Q4 2023 AstraZeneca PLC Earnings Call TranscriptFeb 08, 2024kr1312.5 (-5.98%)Earnings
- AstraZeneca PLC at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Q3 2023 AstraZeneca PLC Earnings Call TranscriptNov 09, 2023kr1407 (+1.59%)Earnings
- Q2 2023 AstraZeneca PLC Earnings Call TranscriptJul 28, 2023kr1501 (+4.16%)Earnings
- AstraZeneca PLC at ASCO Investor Meeting (Virtual) TranscriptJun 05, 2023
- Q1 2023 AstraZeneca PLC Earnings Call TranscriptApr 27, 2023kr1516.5 (-0.39%)Earnings
- Q4 2022 AstraZeneca PLC Earnings Call TranscriptFeb 09, 2023kr1407.5 (+2.36%)Earnings
- Q4 2022 AstraZeneca PLC Earnings Presentation (Pre-Recorded) TranscriptFeb 09, 2023
- Q3 2022 AstraZeneca PLC Earnings Presentation TranscriptNov 10, 2022
- Q2 2022 AstraZeneca PLC Earnings Call TranscriptJul 29, 2022kr1356.5 (-0.51%)Earnings
- AstraZeneca PLC Meet AZN management: American Society of Clinical Oncology 2022 Annual Meeting TranscriptJun 06, 2022
- Q1 2022 AstraZeneca PLC Earnings Call TranscriptApr 29, 2022kr1317.5 (+2.13%)Earnings
- AstraZeneca PLC Investor Science Conference Call: ASCO GU 2022 TranscriptFeb 23, 2022
- Full Year 2021 AstraZeneca PLC Earnings Call TranscriptFeb 10, 2022kr1093.4 (+5.13%)Earnings
- AstraZeneca PLC Investor science conference call: ASCO GI 2022 TranscriptJan 24, 2022
- AstraZeneca PLC at OTC Markets and Deutsche Bank Depositary Receipts Virtual Investor Conference TranscriptNov 17, 2021
- Q3 2021 AstraZeneca PLC Earnings Call TranscriptNov 12, 2021kr1031.2 (-5.95%)Earnings
- AstraZeneca PLC ESMO Investor Science Conference Call TranscriptSep 20, 2021
- Q2 2021 AstraZeneca PLC Earnings Call TranscriptJul 29, 2021kr987.9 (-0.15%)Earnings
- AstraZeneca PLC Meet AZN Management: Oncology - 2021 ASCO Annual Meeting TranscriptJun 07, 2021
- Q1 2021 AstraZeneca PLC Earnings Call TranscriptApr 30, 2021kr896.2 (+3.59%)Earnings
- AstraZeneca PLC BioPharmaceuticals Virtual Event - New CVRM: Emerging Pipeline TranscriptMar 25, 2021
- AstraZeneca PLC BioPharmaceuticals Virtual Event - Opening and Q&A Session TranscriptMar 25, 2021
- Full Year 2020 AstraZeneca PLC Earnings Call TranscriptFeb 11, 2021kr836.7Earnings
- AstraZeneca PLC to Acquire Alexion Pharmaceuticals Inc Call TranscriptDec 12, 2020
- Q3 2020 AstraZeneca PLC Earnings Call TranscriptNov 05, 2020kr971.5 (-0.15%)Earnings
- AstraZeneca PLC Investor Conference Call: Farxiga's DAPA-CKD Trial at ESC 2020 TranscriptAug 30, 2020
- Q2 2020 AstraZeneca PLC Earnings Call TranscriptJul 30, 2020kr1003.8 (+1.62%)Earnings
- AstraZeneca PLC at ASCO Virtual Scientific Program TranscriptJun 01, 2020
- Q1 2020 AstraZeneca PLC Earnings Call TranscriptApr 29, 2020kr1014.8 (+0.32%)Earnings
- Silence Therapeutics PLC Collaboration With AstraZeneca and R&D Update Call TranscriptMar 25, 2020
- Full Year 2019 AstraZeneca PLC Earnings Call TranscriptFeb 14, 2020kr925.7 (-3.17%)Earnings
- AstraZeneca PLC Investor Science Conference Call - ASH 2019 TranscriptDec 10, 2019
- AstraZeneca PLC Investor Science Conference Call - ACR 2019 TranscriptNov 13, 2019
- AstraZeneca PLC Investor Science Conference Call - ASN 2019 TranscriptNov 10, 2019
- Q3 2019 AstraZeneca PLC Earnings Call TranscriptOct 24, 2019kr909 (+5.21%)Earnings
- AstraZeneca PLC Investor Science Conference Call: ESMO 2019 TranscriptSep 30, 2019
- AstraZeneca PLC Investor Science Conference Call: Farxiga's DAPA-HF trial at ESC TranscriptSep 01, 2019
- Q2 2019 AstraZeneca PLC Earnings Call TranscriptJul 25, 2019kr818.8 (+7.77%)Earnings
- AstraZeneca PLC at ASCO Annual Meeting TranscriptJun 03, 2019
- AstraZeneca PLC Annual Shareholders Meeting TranscriptApr 26, 2019
- Q1 2019 AstraZeneca PLC Earnings Call TranscriptApr 26, 2019kr721.2 (-2.00%)Earnings
- AstraZeneca PLC to Discuss Strategic Collaboration in Oncology of Trastuzumab Deruxtecan (DS-8201) with Daiichi Sankyo Co Ltd Call TranscriptMar 29, 2019
- Daiichi Sankyo Co Ltd and AstraZeneca PLC DS-8201 Strategic Collaboration Presentation TranscriptMar 29, 2019
- Full Year 2018 AstraZeneca PLC Earnings Call TranscriptFeb 14, 2019kr741.5 (+8.25%)Earnings
Q4 2022 AstraZeneca PLC Earnings Presentation (Pre-Recorded) Transcript
Feb 09, 2023 / NTS GMT
Release Date Price:
kr1407.5
(+2.36%)
Pascal Soriot
AstraZeneca PLC - CEO & Executive Director
Presentation (Pre-Recorded)
Feb 09, 2023 / NTS GMT
=====================
Corporate Participants
=====================
* Pascal Soriot
AstraZeneca PLC - CEO & Executive Director
=====================
-
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)